Skip to content
Menu

ImageneBio, Inc. IMA

Full chart Compare
Set alert

Price alert · IMA

All alert types
3.47 USD -0.02 (-0.57%)

Regular-session close

3.47 0.00 0.00%

After hours · Nov 13, 4:00 PM ET

3.34 Day range 3.58
3.34 52-week range 8.25
YTD
-49.71%
1 year
-58.34%

Revenue & Expenses

Other Income → Expenses: $2.75MOther Operating Income → Expenses: $1.03MExpenses → Gross Loss: $233.00KExpenses → Selling, General & Admin: $20.73MExpenses → Research & Development: $28.52MIncome Tax Benefit → Expenses: $350.00KNet Loss → Expenses: $45.35MRevenue → Cost of Revenue: $800.00KOther Income$2.75MOther Operating Income$1.03MIncome Tax Benefit$350.00KNet Loss$45.35MCost of Revenue$1.03MExpenses$49.48MGross Loss$233.00KSelling, General & Admin$20.73MResearch & Development$28.52MRevenue$800.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

IMA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
800.00K3.50M9.16M15.62M30.98M
800.00K3.50M9.16M15.62M30.98M
-48.45M-37.00M-75.42M-70.90M-34.14M
-45.35M-36.57M-68.17M-68.77M-34.12M
-9.64-22.10-19.60-22.80-14.60
IMA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
94.53M12.12M119.89M59.92M232.22M
152.98M15.92M192.09M172.26M247.88M
19.84M17.45M22.34M25.29M40.00M
2.98M8.05M10.74M5.69M6.99M
133.14M-160.56M169.76M146.97M207.88M
IMA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-47.84M-21.32M-79.74M-74.11M-60.25M
-5.81M11.12M64.14M-99.28M-1.76M
135.47M6.91M75.98M1.09M131.74M
82.41M-3.20M60.38M-172.30M69.73M